PROXY STATEMENT

Company

Allarity Therapeutics, Inc.

Filed

July 1, 2024

Period of Report

July 26, 2024

Accession Number

0001213900-24-057937

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →